BETTER CELLS. BETTER OUTCOMES.
Dead / Abandoned — Abandoned — failure to respond (as of 12 Sept 2019)
What this means for you
This application is over — abandoned 13 Aug 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88167472
- Mark type
- Stylized text
- Filed
- 24 Oct 2018
- Abandoned
- 13 Aug 2019
- Attorney of record
- Ernest V. Linek
Goods and services
- Class 005 — Pharmaceuticals: Expansion of stem cells for therapeutic purposes, including hematopoietic (blood) stem cell transplantation (HSCT) for patients with blood cancers; small molecules and bioengineering solutions to expand cells for therapeutic use to patients with blood cancers and other diseases
- Class 042 — Scientific and technological services: Medical and scientific research in the field of stem cells; medical laboratory research; medical and scientific research namely, conducting pre-clinical and clinical trials
Owner
- ExcellThera Inc., Montreal, Quebec, CA
Prosecution history
- 12 Sept 2019 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 12 Sept 2019 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 12 Feb 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Feb 2019 — NON-FINAL ACTION E-MAILED
- 12 Feb 2019 — NON-FINAL ACTION WRITTEN
- 31 Jan 2019 — ASSIGNED TO EXAMINER
- 06 Nov 2018 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Oct 2018 — NEW APPLICATION ENTERED